🇺🇸 FDA
Pipeline program

Fespixon Cream

ON101CLAS08

Approved small_molecule terminated

Quick answer

Fespixon Cream for Diabetic Foot Ulcer (DFU) is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Diabetic Foot Ulcer (DFU)
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials